| Alexei J. Marko |
Alexei J. Marko is currently the Chief Executive Officer & Director at Human in Motion Robotics, Inc. He also holds the position of Non-Independent Director at Neovasc, Inc. Additionally, he is a Director at the Medical Device Development Centre. Previously, Mr. Marko served as the President & Chief Executive Officer at Angiometrx, Inc. from 1999 to 2008. He was also the President & Chief Operating Officer at Medical Ventures Corp. from 2007 to 2008. Mr. Marko completed his undergraduate degree at Queen's University and his graduate degree at the University of British Columbia. |
| Sarah Gallagher |
Sarah Gallagher is currently the Vice President-Clinical Affairs at Neovasc, Inc. She completed her undergraduate degree at the University of Minnesota and her graduate degree at the University of St. Thomas. |
| Shmuel Banai |
Shmuel Banai is currently working as a Medical Director at Neovasc, Inc., a Professor at Tel-Aviv University, an Associate Professor at The Hebrew University Hadassah Medical School, and a Professor at Sackler School of Medicine. He previously worked as a Director at Augwind Energy Tech Storage Ltd., a Medical Director at Neovasc Medical Ltd., a Director-Heart Institute at Hadassah University Hospital, and a Director-Interventional Cardiology at Tel-Aviv Sourasky Medical Center. He also served as an Associate Director at Bikur Cholim Hospital from 1992 to 2003 and as a Chief Medical Officer at Innovea Medical Ltd. in 2009-2010. Dr. Banai holds a doctorate degree from The Hebrew University of Jerusalem. |
| Paul L. Geyer |
Paul L. Geyer founded Medical Ventures Corp. in 2002, where he worked as Chairman & Chief Executive Officer from 2002 to 2008 and Mitroflow International, Inc. in 1991, where he worked as President & Chief Executive Officer from 1991 to 2001. Mr. Geyer also currently works at Nimbus Synergies, Inc., as Chief Executive Officer from 2017, Nimbus Synergies, Inc., as Chief Executive Officer from 2017, Quimby Investments Ltd., as Chief Executive Officer, and various other companies. Mr. Geyer also formerly worked at Disani Capital Corp., as Board of Directors from 2001 to 2004, Venturi Ventures, Inc., as Director from 2004 to 2010, Pitchstone Exploration Ltd., as Director in 2005, and various other companies. Mr. Geyer received his undergraduate degree from Queen's University and undergraduate degree in 1988 from the University of British Columbia. |
| John Panton |
John Panton currently works at Neovasc, Inc., as Chief Quality Officer from 2020. |
| Steven D. Rubin |
Steven D. Rubin is currently the Chairman at Neovasc, Inc. and the Vice Chairman at Cocrystal Pharma, Inc. He also holds positions as a Director at Bio-Reference Laboratories, Inc., OPKO Biologics Ltd., OPKO Health, Inc., Chromadex Corp., Red Violet, Inc., and Eloxx Pharmaceuticals, Inc. Additionally, he is an Independent Director at Weil, Gotshal & Manges LLP. In the past, Mr. Rubin served as Chairman at B-Balloon Ltd. and SciVac Therapeutics, Inc. He was also an Independent Director at Non-Invasive Monitoring Systems, Inc., Cellular Technical Services Co., Inc., Dreams, Inc., clickNsettle.com, Inc., Sevion Therapeutics, Inc., Castle Brands, Inc., Longfoot Communications Corp., Ideation Acquisition Corp., IDI, Inc. (United States), Stearns Weaver Miller Weissler Alhadeff & Sitterson PA, SafeStitch Medical, Inc., Cocrystal Discovery, Inc., Kidville, Inc., Tiger X Medical, Inc., Fluent, Inc., BioZone Pharmaceuticals, Inc., Eloxx Pharmaceuticals Ltd., Asensus Surgical, Inc., VBI Vaccines, Inc., BioCardia, Inc., Cogent, Inc., IVAX LLC, eXegenics, Inc., Telergy, Inc., and The Frost Group LLC. Mr. Rubin completed his undergraduate degree at Tulane University (Louisiana) and his graduate degree at the University of Florida. |
| Christopher Clark |
Christopher Clark is currently the Director at Aequus Pharmaceuticals, Inc. since 2014 and the Secretary at Neovasc, Inc. since 2007. He previously worked as the Finance Director at Disani Capital Corp. from 2004 to 2005 and at Mr. Lube Canada LP from 2005 to 2007. He also served as the Chief Financial Officer at Medical Ventures Corp. Mr. Clark completed his undergraduate degree at Swansea University. |
| Douglas Glen Janzen |
Douglas Glen Janzen is the founder of Northview LifeSciences (founded in 2014), Aequus Pharmaceuticals, Inc. (founded in 2013), Northview Ventures, Inc. (founded in 2012), and Northview Ventures & Associates General Partnership (founded in 2014). He is currently the Chairman of Lexington Biosciences Holdings Corp., Director & Managing Director of LifeSciences British Columbia, Independent Director of Neovasc, Inc., Director of Synaptive Technologies Ltd., Director of Transdermal Research Pharm Laboratories LLC, and Director of Alabaster Technologies, Inc. He has previously held positions as President, Chief Executive Officer & Director of Correvio Pharma Corp. (2003-2012), Chairman of AbCellera Biologics, Inc., Chairman of Lexington Biosciences, Inc. (2016-2021), Chairman of Perimeter Medical Imaging, Inc., Director of Medical Ventures Corp., Director of Teal Valley Health, Inc., Director of Aptamera, Inc., Director of Synaptive Medical, Inc., Director of BIOTECanada, Independent Director of iCo Therapeutics, Inc. (2012-2015), Director of Sentinelle Medical ULC, Director of BioHEP Technologies Ltd., Director of Renaissance BioScience Corp., Director of AmpHP, Inc., Director of Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. (2002), President & Chief Business Officer of Bradmer Pharmaceuticals, Inc. (2006-2007), and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. (1998-2001). He holds a graduate degree from the University of British Columbia and an undergraduate degree from the University of Saskatchewan. |
